Event Summary: How to Break Into Science Writing
In late April, Rudy Bellani, founder and CEO of Oystir, came to Rutgers and gave career advice and information about his company. For more about Rudy, see Myka Ababon’s interview here.
In late April, Rudy Bellani, founder and CEO of Oystir, came to Rutgers and gave career advice and information about his company. For more about Rudy, see Myka Ababon’s interview here.
By: Chris Lowe
The advice to keep unprofessional or embarrassing pictures from Facebook and Instagram has long been impressed on all of us. But why not take it one step further?
The iJOBS program organized a visit to the Eli Lilly and Company site in Branchburg, NJ on April 6th of this year. Eli Lilly and Company was founded over 140 years ago and has a long history of quality pharmaceutical products including several well-known drugs such as Cialis, Cymbalta, and Prozac. The morning of our visit, we were greeted by the smiling face of human resources manager
One of the most oft-repeated advice for students and postdocs on a career search is to NETWORK, NETWORK, NETWORK.
On January 26 of this year, the iJOBS program took a trip to East Hanover, NJ to visit the Novartis campus. I say ‘campus’ because this place felt like a community, not a business. Overall, the atmosphere was inviting and everyone we met seemed genuinely happy to be working there. Several employees emphasized how Novartis encourages a place of diversity and comradery, and what a great overall place it is to work.
Last week, iJOBS hosted a career panel featuring professionals from WuXiAppTec. This panel operated slightly differently than previous ones in that the panel featured a single company rather than showcasing a single career with individuals from different companies. There were two PhD scientists, an HR representative, and a recruitment officer at the panel-this allowed for a well-rounded view of the company.
By: Chris Lowe
Friday, January 15, 2016 was landmark day for a group of 35 young scientists at Rutgers University. While the typical pathway to FDA review of a new drug, including discovery, development, preclinical studies, and clinical trials, requires more than a decade of work and hundreds of dedicated chemists, scientists, and clinicians, the students of the 3rd Annual Interdisciplinary Boot Camp in Quantitative Biology were able to take a drug through this process in just two weeks.